AI assistant
Nova Agritech Limited — Capital/Financing Update 2024
Aug 12, 2024
59150_rns_2024-08-12_8d50d476-78f4-4f46-b603-5c05016a0f8e.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Registered Office: Sy.No.251/A/1., Singannaguda Village Mulugu Mandal, Medak, Siddipet - 502279, Telangana, India
==> picture [130 x 61] intentionally omitted <==
CIN : L01119TG2007PLC053901
+91 84 5425 3446 • [email protected]
12[th] August, 2024
To
BSE Limited ,
Listing Department, P J Towers,
Dalal Street, Mumbai – 400 001
Scrip Code: 544100
National Stock Exchange of India Limited ,
Listing Department, Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051
Trading Symbol: NOVAAGRI
SUB: MONITORING AGENCY REPORT FOR THE QUARTER ENDED 30[TH] JUNE, 2024.
Ref: Regulation 32(6) of the SEBI (LODR) Regulations, 2015 read with Regulation 41(4) of SEBI (ICDR) Regulations, 2018.
Dear Sir/Madam,
With reference to the aforesaid cited, attached herewith is the Monitoring Agency Report w.r.t. utilization of proceeds of Initial Public Offer (IPO) of Nova Agritech Limited for the quarter ended 30[th] June, 2024 issued by CARE Ratings Limited, Monitoring Agency appointed by the Company in this regard.
The Monitoring Agency Report is also available on the website of the Company i.e. https://novaagri.in/investor-relations/notices-and-disclosures/.
Please take the same on record and suitably disseminate it to all concerned.
Thanking you!
For Nova Agritech Limited
NEHA Digitally signed by NEHA SONI Date: 2024.08.12 SONI 14:57:08 +05'30'
Neha Soni
Company Secretary & Compliance Officer
Encls: Monitoring Agency Report for the quarter ended 30[th] June, 2024
==> picture [137 x 37] intentionally omitted <==
No. CARE/HRO/GEN/2024-25/1019
The Board of Directors Nova Agritech Limited
Sy. No. 251/A/1, Singannanguda Village, Mulugu Mandal, Siddipet, Medak, Telangana- 502279
10/08/2024
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended 30/06/2024 - in relation to the IPO of Nova Agritech Limited (“the Company”)
We write in our capacity of Monitoring Agency for the Initial Public Offering for the amount aggregating to Rs. 143.81 crore of the Company and refer to our duties cast under Regulation 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended 06/30/2024 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated 12/28/2023.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
==> picture [56 x 20] intentionally omitted <==
Niraj Thorat
Assistant Director [email protected]
CARE Ratings Ltd.
1
==> picture [137 x 38] intentionally omitted <==
Report of the Monitoring Agency
Name of the issuer: Nova Agritech Limited For quarter ended: 06/30/2024 Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: Nil
(b) Range of Deviation: Not Applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
==> picture [57 x 20] intentionally omitted <==
Signature: Name and designation of the Authorized Signatory: Niraj Thorat Designation of Authorized person/Signing Authority: Assistant Director
CARE Ratings Ltd.
2
==> picture [138 x 38] intentionally omitted <==
1) Issuer Details:
Name of the issuer Name of the promoter
Industry/sector to which it belongs
: Nova Agritech Limited : Suraksha Agri Retails (India) Private Limited Yeluri Family Trust Malathi S Kiran Kumar Atukuri : Agriculture (Agri Input Industry)
2) Issue Details
Issue Period : 01/23/2024 to 01/25/2024 Type of issue (public/rights) : Public Fresh Issue Type of specified securities : Equity Shares IPO Grading, if any : Not Applicable Issue size (in crore) : Rs. 112.00 Crore
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
| Particulars | Reply | Source of information / certifications considered by Monitoring Agency for preparation of report |
Comments of the Monitoring Agency |
Comments of the Board of Directors |
|---|---|---|---|---|
| Whether all utilization is as per the disclosures in the Offer Document? |
Yes | CA certificate*, Bank statements | The net proceeds of the issue are Rs.100.95 crore out of which Rs.40.06 crore was spent as on June 30,2024. |
- |
| Whether shareholder approval has been obtained in case of material deviations# from expenditures disclosed in the Offer Document? |
Not Applicable |
Not Applicable | Not Applicable | - |
| Whether the means of finance for the disclosed objects of the issue have changed? |
No | Not Applicable | No | - |
| Is there any major deviation observed over the earlier monitoring agency reports? |
Not Applicable |
Not Applicable | All the proceeds from Fresh Issue have been utilized appropriately for the objectives mentioned in the offer document. |
- |
CARE Ratings Ltd.
3
==> picture [138 x 38] intentionally omitted <==
| Particulars | Reply | Source of information / certifications considered by Monitoring Agency for preparation of report |
Comments of the Monitoring Agency |
Comments of the Board of Directors |
|---|---|---|---|---|
| Whether all Government/statutory approvals related to the object(s)have been obtained? |
Not Applicable |
Not Applicable | Not Applicable | - |
| Whether all arrangements pertaining to technical assistance/collaboration are in operation? |
Not Applicable |
Not Applicable | Not Applicable | - |
| Are there any favorable/unfavorable events affecting the viabilityof these object(s)? |
No | Not Applicable | No | - |
| Is there any other relevant information that may materially affect the decision makingof the investors? |
No | Not Applicable | No | - |
- *Chartered Accountant certificate from NSVR & Associates LLP dated August 08, 2024
Where material deviation may be defined to mean:
a) Deviation in the objects or purposes for which the funds have been raised
b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents.
4) Details of objects to be monitored:
(i) Cost of objects –
| Sr. No |
Item Head |
Source of information / certifications considered by Monitoring Agency for preparation of report |
Original cost (as per the Offer Document) in Rs. Crore |
Comments of the Board of Directors | Comments of the Board of Directors | Comments of the Board of Directors | ||
|---|---|---|---|---|---|---|---|---|
| Revised Cost in Rs. Crore |
Comments of the Monitoring Agency |
Reason for cost revision |
Proposed financing option |
Particulars of - firm arrangements made |
||||
| 1 | Investment in subsidiary, Nova Agri Sciences Private Limited for setting-up a new formulationplant |
Chartered Accountant certificate*, Final Prospectus |
14.20 | Not Applicable | NA | - | - | - |
| 2 | Funding Capital Expenditure by Company, towards expansion of existingformulationplant |
Chartered Accountant certificate*, Final Prospectus |
10.49 | Not Applicable | NA | - | - | - |
| 3 | Funding of working capital requirement of the company |
Chartered Accountant certificate*,Final Prospectus |
26.65 | Not Applicable | NA | - | - | - |
CARE Ratings Ltd.
4
==> picture [138 x 38] intentionally omitted <==
| 4 | Investment in the subsidiary, Nova Agri Sciences Private Limited, for funding working capital requirements. |
Chartered Accountant certificate*, Final Prospectus |
43.36 | Not Applicable | NA | - | - | - |
|---|---|---|---|---|---|---|---|---|
| 5 | General corporate purpose | Chartered Accountant certificate*, Final Prospectus |
6.24 | Not Applicable | As per the offer document, the original cost for GCP is mentioned as Rs 3.13 crore. However, the company has clarified that the amount was erroneously mentioned as Rs.3.13 crore as issue related expenses pertaining to offer for sale (Rs.3.12 crore) was considered along with issue related expenses of IPO. However, the same was rectified subsequently and GCP amount has increased to that extent. The same was informed to SEBI And a corrigendum^ has been issued by the company on direction of SEBI on January29,2024 |
- | - | - |
| Total | 100.95 |
*Chartered Accountant certificate from NSVR & Associates LLP dated August 08, 2024.
(ii) Progress in the objects –
CARE Ratings Ltd.
5
==> picture [138 x 38] intentionally omitted <==
| Sr. No |
Sr. No |
Item Head |
Item Head |
Source of information / certifications considered by Monitoring Agency for preparation of report |
Comments of the Board of Directors |
Comments of the Board of Directors |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amount as proposed in the Offer Document in Rs. Crore |
Amount utilised in Rs. Crore | Total unutilise |
Comments of the Monitoring Agency |
|||||||||
| As at beginnin g of the quarter in Rs. Crore |
Reasons for idle funds |
Proposed course of action |
||||||||||
| At the | d | |||||||||||
| During the |
end of the | amount | ||||||||||
| quarter in Rs. |
quarter in | in Rs. crore |
||||||||||
| Crore | Rs. Crore | |||||||||||
| 1 | Investment in subsidiary, Nova Agri Sciences Private Limited for setting-up a new formulation plant |
CA certificate*, Bank statements |
14.20 | - | - | - | 14.20 | Rs. 3.00 crore was supposed to be spent for the object in Q4FY24 which the company has not utilised. However, the offer document states that if the proceeds are not utilised in the respective periods, it can be utilised in the subsequentperiods. |
- | - | ||
| 2 | Funding Capital Expenditure by Company, towards expansion of existing formulation plant |
CA certificate*, Bank statements |
10.49 | - | - | - | 10.49 | Rs. 2.50 crore was supposed to be spent for the object in Q4FY24 which the company has not utilised. However, the offer document states that if the proceeds are not utilised in the respective periods, it can be utilised in the subsequentperiods. |
- | - | ||
| 3 | Funding of working capital requirement of the company |
CA certificate*, Bank statements |
26.65 | 4.77 | 12.26 | 17.03 | 9.62 | On April 06, 2024, Rs 10.00 crore have been transferred from MA account to CC account of Nova Agritech Limited for the working capital requirement of the company. On April 19, 2024, Rs 10.00 crore was again transferred |
- | - | ||
| 6 | CARE Ratings Ltd. |
CARE Ratings Ltd.
6
==> picture [138 x 38] intentionally omitted <==
| Sr. No |
Item Head |
Source of information / certifications considered by Monitoring Agency for preparation of report |
Comments of the Board of Directors |
Comments of the Board of Directors |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Amount as proposed in the Offer Document in Rs. Crore |
Amount utilised in Rs. Crore | Total unutilise |
Comments of the Monitoring Agency |
|||||||
| As at beginnin g of the quarter in Rs. Crore |
Reasons for idle funds |
Proposed course of action |
||||||||
| At the | d | |||||||||
| During the |
end of the | amount | ||||||||
| quarter in Rs. |
quarter in | in Rs. crore |
||||||||
| Crore | Rs. Crore | |||||||||
| from MA account to CC account of Nova Argritech Limited out of which Rs 2.26 crore was used for working capital requirement of the company |
||||||||||
| 4 | Investment in the subsidiary, Nova Agri Sciences Private Limited, for funding working capital requirements. |
CA certificate*, Bank statements |
43.36 | 9.06 | 7.74 | 16.80 | 26.56 | In Q1FY25, Rs 16.80 crore was transferred to OCD account of the subsidiary company NASPL from the CC account of NAL instead of direct transfer from MA account. Out of received amount Rs. 15.60 crore was transferred to CC account of NASPL for their working capital requirement. |
- | - |
| 5 | General corporate purpose | CA certificate* | 6.23 | 6.23 | - | 6.23 | 0.00 | On February 23, 2024, the company has debited Rs 1.65 crore and on March 05, 2024, the company has debited Rs 4.58 crore totalling Rs. 6.23 crore for GCP. |
- | - |
| Total | 100.95 | 20.06 | 20.00 | 40.06 | 60.89 |
*Chartered Accountant certificate from NSVR & Associates LLP dated August 08, 2024.
CARE Ratings Ltd.
7
==> picture [138 x 38] intentionally omitted <==
(iii) Deployment of unutilized proceeds:
| Sr. No. | Type of instrument and name of the entity invested in |
Amount invested | Maturity date | Earning | Return on Investment (%) |
Market Value as at the end of quarter |
|---|---|---|---|---|---|---|
| 1 | Fixed Deposit-Union Bank of India | 10.00 | 28-03-2025 | - | 7.62 | - |
| 2 | Fixed Deposit- ICICI Bank | 11.89 | 29-03-2025 | - | 7.65 | - |
| 3 | Fixed Deposit-Union Bank of India | 10.00 | 09-10-2024 | - | 6.50 | - |
| 4 | Fixed Deposit-Union Bank of India | 10.00 | 10-12-2024 | - | 7.20 | - |
| 5 | Fixed Deposit- ICICI Bank | 5.10 | 11-07-2024 | - | 5.50 | - |
| 6 | Fixed Deposit- ICICI Bank | 5.10 | 11-08-2024 | - | 6.00 | - |
| 7 | Fixed Deposit- ICICI Bank | 5.10 | 11-09-2024 | - | 6.50 | - |
| 8 | Balance in IPO monitoringaccount | 3.72 | ||||
| 9 | Balance in Public Issue account | 2.42 | ||||
| Total | 63.33 | |||||
Note:
| Note: | |
|---|---|
| Unutilized netproceeds | Rs 60.89 |
| Issue related expenses to be spent towards IPO | Rs 2.22 |
| Issue related expenses towards OFS | Rs 0.14 |
| Funds to be transferred to selling shareholder | Rs 0.08 |
| Total unutilized amount | Rs 63.33 |
(iv) Delay in implementation of the object(s) –
| Objects | Objects | Completion Date | Completion Date | Delay (no. of days/ months) |
Comments of the Board of Directors |
Comments of the Board of Directors |
|---|---|---|---|---|---|---|
| As per the offer document |
Actual | Reason of delay |
Proposed course of action |
|||
| Investment in subsidiary, Nova Agri Sciences Private Limited for setting-up a new formulationplant |
FY24: Rs 3.00 crore FY25: Rs 11.20 crore |
Nil |
Ongoing | - | - | |
| FundingCapital Expenditure byCompany,towards expansion of existingformulation | FY24: Rs 2.50 crore | Nil | Ongoing | - | - | |
| 8 | CARE Ratings Ltd. |
==> picture [138 x 38] intentionally omitted <==
| Objects | Completion Date | Completion Date | Delay (no. of days/ months) |
Comments of the Board of Directors |
Comments of the Board of Directors |
|---|---|---|---|---|---|
| As per the offer document |
Actual | Reason of delay |
Proposed course of action |
||
| plant | FY25: Rs 7.99 crore | ||||
| Funding of working capital requirement of the company | FY24: Rs 4.77 crore FY25: Rs 12.26 crore |
FY24: Rs 4.77 crore FY25: Rs 12.26 crore |
Not Applicable | - | - |
| Investment in the subsidiary, Nova Agri Sciences Private Limited, for funding working capital requirements. |
FY24: Rs 9.06 crore FY25: Rs 22.03 crore |
Rs 16.80 Crore |
Not Applicable | - | - |
| General corporatepurpose | Rs 6.23 Crore | Rs 6.23 | Not Applicable | - | - |
- *The company has not made any investment in subsidiary, NASPL for setting up a new formulation plant and funding capital expenditure by NAL for expansion of its existing facility till Q1FY25. However, the company has indicated that the investments for capex has started from July, 2024 onwards.
5) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document:
| Source of information / certifications | |||||
| Amount | |||||
| Sr. No | Item Head^ | considered by Monitoring Agency for | Comments of Monitoring Agency | Comments of the Board of Directors | |
| in Rs. Crore | |||||
| preparation of report | |||||
| 1 | General Corporate Purpose | 6.23 | GCP proceeds were utilized towards working capital requirements of Nova Agritech Limited. |
- |
|
| CA certificate*, Bank Statement | |||||
| Total | 6.23 |
*Chartered Accountant certificate from NSVR & Associates LLP dated August 08, 2024.
^ Section from the offer document related to GCP:
CARE Ratings Ltd.
9
==> picture [138 x 38] intentionally omitted <==
==> picture [752 x 239] intentionally omitted <==
CARE Ratings Ltd.
10
==> picture [137 x 38] intentionally omitted <==
Disclaimers to MA report:
a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as “Monitoring Agency/MA” ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.
b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditors (or from peer reviewed CA firms) appointed by the Issuer believed by it to be accurate and reliable.
c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report.
d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives from auditors (or from peer reviewed CA firms), lawyers, chartered engineers or other experts, and relies on in its reports.
e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued by the issuer that is subject matter of this report. The MA may receive separate compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors.
11